263 related articles for article (PubMed ID: 8905215)
21. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
22. Kidney disease in diabetology: lessons from 2008.
Schernthaner G
Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
[No Abstract] [Full Text] [Related]
23. Management of nephropathy in patients with type 2 diabetes.
Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
[TBL] [Abstract][Full Text] [Related]
24. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
25. [The kidneys and diabetes].
Rüster C; Sämann A; Wolf G
Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
[No Abstract] [Full Text] [Related]
26. [Diabetes mellitus, hypertension and kidney].
Monhart V
Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
[TBL] [Abstract][Full Text] [Related]
27. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
28. Diabetic nephropathy.
Berezin M
Isr J Med Sci; 1991 Apr; 27(4):213-5. PubMed ID: 2010275
[No Abstract] [Full Text] [Related]
29. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
[TBL] [Abstract][Full Text] [Related]
30. [Albuminuria in the diabetic patient: practical management].
Kistler AD
Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233
[TBL] [Abstract][Full Text] [Related]
31. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy.
Parving HH
Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612
[No Abstract] [Full Text] [Related]
32. [Renal failure secondary to diabetic nephropathy. A review of the characteristics of the diabetic patients who started dialysis in Catalonia in 1994].
González MT; Castell C; Esmatjes E; Tresserras R; de Lara N; Lloveras G
Rev Clin Esp; 1999 Jan; 199(1):8-12. PubMed ID: 10089770
[TBL] [Abstract][Full Text] [Related]
33. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
Molitch ME
Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
[TBL] [Abstract][Full Text] [Related]
34. [Strategies to reduce the progression of renal disease in patients with type II diabetes mellitus].
Burgos Calderón R
P R Health Sci J; 2001 Jun; 20(2):157-60. PubMed ID: 11561475
[TBL] [Abstract][Full Text] [Related]
35. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
[TBL] [Abstract][Full Text] [Related]
36. Expert consensus on management of diabetic patients with impairment of renal function.
Bonnet F; Gauthier E; Gin H; Hadjadj S; Halimi JM; Hannedouche T; Rigalleau V; Romand D; Roussel R; Zaoui P
Diabetes Metab; 2011 Sep; 37 Suppl 2():S1-25. PubMed ID: 22108432
[No Abstract] [Full Text] [Related]
37. [Advanced microangiopathic complications at the diagnosis of diabetes mellitus].
Pátkai G; Farkas K; Hegedús J; Jermendy G
Orv Hetil; 2001 Aug; 142(31):1687-90. PubMed ID: 11556263
[TBL] [Abstract][Full Text] [Related]
38. [CAPD (continuous ambulatory peritoneal dialysis) in diabetic nephropathy: overview and general practice in the Lainz Hospital since 1982].
Auinger M
Acta Med Austriaca; 1999; 26(5):154-8. PubMed ID: 11512192
[TBL] [Abstract][Full Text] [Related]
39. [The treatment of acute suppurative pyelonephritis in diabetes mellitus patients].
Dovlatian AA
Ter Arkh; 1993; 65(10):35-9. PubMed ID: 8296230
[TBL] [Abstract][Full Text] [Related]
40. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
